key: cord-1054669-j93vbdtz
authors: a Beccara, Lia; Pacioni, Carlotta; Ponton, Sara; Francavilla, Simone; Cuzzoli, Antonio
title: Arterial Mesenteric Thrombosis as a Complication of SARS-CoV-2 Infection
date: 2020-04-30
journal: Eur J Case Rep Intern Med
DOI: 10.12890/2020_001690
sha: b23cac0612d57e9423715244000640cfa844178d
doc_id: 1054669
cord_uid: j93vbdtz

A 52-year-old patient with SARS-CoV-2 was diagnosed with interstitial pneumonia and treated with darunavir/ritonavir, hydroxychloroquine, azithromycin and low molecular weight heparin (LMWH). After LMWH cessation, he developed superior mesenteric arterial thrombosis. An abdominal CT scan showed arterial thrombosis of vessels efferent of the superior mesenteric artery with bowel distension. COVID-19 may predispose to venous and arterial thromboembolism. Anticoagulation prophylaxis should be considered in hospitalized patients with COVID-19, and potential thromboembolism investigated in each symptomatic patient affected by SARS-CoV-2. LEARNING POINTS: Potential thromboembolism must be investigated in each symptomatic patient with SARS-CoV-2 infection. The preventive and therapeutic use of antithrombotic agents should be strongly considered in order to mitigate thrombotic and haemorrhagic events in patients with SARS-CoV-2 infection.

INTRODUCTION SARS-CoV-2 infection has spread rapidly throughout the world, causing millions of infections and nearly 200,000 deaths at the time of writing [1] , and was declared a pandemic by the WHO on 11 March 2020 [2] . Autopsy examinations have demonstrated microcirculation damage and thrombosis with venous and arterial microembolism [3] . COVID-19 may predispose to both venous and arterial thromboembolism due to excessive inflammation, hypoxia, immobilization and diffuse intravascular coagulation [4, 5] . No cases of arterial mesenteric embolism have been reported in the current literature. We describe the case of a 52-year-old patient with SARS-CoV-2 who developed superior mesenteric arterial thrombosis.

A 52-year-old man was admitted to the emergency room of Cremona hospital on 27 March. He presented with a 10-day history of cough and fever but no other past illnesses. For the previous 3 days he had been treated with azithromycin 500 mg once a day and hydroxychloroquine 200 mg twice a day as prescribed by his general practitioner. A nasopharyngeal swab was obtained. Blood tests, arterial blood gas analysis and a thoracic CT scan were performed, demonstrating interstitial pneumonia and acute respiratory insufficiency, which was initially treated with oxygen. The nasopharyngeal swab tested positive for SARS-CoV-2. The patient was admitted to our medical department with the diagnosis of interstitial pneumonia due to SARS-CoV-2. He started antiretroviral therapy with darunavir/ritonavir 800/100 mg a day, hydroxychloroquine 200 mg twice a day, azithromycin 500 mg once a day and low molecular weight heparin (LMWH) 4,000 U daily, according to hospital protocol. The patient improved clinically and was discharged from hospital on 4 April (after 7 days of hospitalization), without fever or cough and with a prescription for hydroxychloroquine twice a day until 7 April. However, on 8 April, the patient complained of fever (37.5°C), which was treated with paracetamol, and two episodes of diarrhoea and was admitted the next day to the emergency department for vomiting and abdominal pain. His blood pressure was 120/70 mmHg, oxygen saturation was 99% on room air, heart rate was 90 bpm, and temperature was 36.3°C. The abdomen was soft, not distended, and painful to palpation in the epigastric-mesogastric region. Blood tests demonstrated a regular white cell count and C-reactive protein (CRP) of 44 mg/dl (lower than the previous value of 65 mg/dl at hospital discharge). An abdominal x-ray and ultrasound were performed, proving negative for abdominal disease. The patient started combination therapy with continuous infusion of omeprazole as a gastroprotectant and intravenous fentanest 100 µg as a painkiller and was monitored in the emergency department. He was still symptomatic 4 hours after fentanest administration and therefore underwent an abdominal contrast-enhanced CT scan, which resulted negative for abdominal effusion and demonstrated no vascular abnormalities. Gastroscopy was requested. During the night the patient's symptoms improved but the next morning he complained of fever, and his clinical conditions worsened without clinical signs of acute abdomen. Blood analysis showed leucocytosis (30,000 white blood cells) and CRP 222 mg/dl. An urgent surgical consultation was requested and a new abdominal CT scan showed arterial thrombosis of vessels efferent of the superior mesenteric artery with bowel distension (Fig. 1) . Surgical examination confirmed the intestinal ischaemia. An intestinal resection with stapled side-to side anastomosis was performed. The patient was discharged from hospital 10 days after surgery, with regular bowel function. He was instructed to continue LMWH plus aspirin 100 mg per day. 

Our patient was discharged from the medical department after 7 days of treatment with LMWH at a prophylactic dose, but developed mesenteric arterial thrombosis 5 days after cessation of heparin. This case supports the administration of anticoagulation prophylaxis in hospitalized patients with COVID-19 and the need to investigate potential thromboembolism in each symptomatic patient affected by SARS-CoV-2.

World Health Organization

World Health Organization. WHO announces COVID-19 outbreak a pandemic

SARS-CoV-2 and viral sepsis: observations and hypotheses

COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up

Incidence of thrombotic complications in critically ill ICU patients with COVID-19